Table 1 Overview of studies on chromosome 16 changes in columnar cell lesions of the breast

From: Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification

Chromosomal arm

Author

Method

DNA marker

Location

Type of CCL

Gains (G) /losses (L)

Frequency (%)

Absolute numbers

16p

Simpson et al. [6]

CGH

  

CCL without atypia

G

16%

4/25

Simpson et al. [6]

CGH

  

CCL with atypia

G

20%

2/10

16q

Simpson et al. [6]

CGH

  

CCL without atypia

L

32%

8/25

Go et al. [25]

FISH

 

16q12.3–13; 16q22.1; 16q23.2

CCL without atypia

Heteroz del

0%

0/19

Ellsworth et al. [24]

LOH

 

16q11.2– 22.1

CCL with/without atypia

 

7%

3/42

Ellsworth et al. [24]

LOH

 

16q22.3– 24.3

CCL with/without atypia

 

5%

2/42

Moinfar et al. [5]

LOH

D16S518

16q23.1–24.2

CCL with atypia

 

33%

2/6

Moinfar et al. [5]

LOH

D16S402

16q24.2

CCL with atypia

 

27%

3/11

Aulmann et al. [23]

LOH

D16S539

16q24

CCL with atypia

 

27%

3/11

Aulmann et al. [23]

LOH

D16S2624

16q22.3

CCL with atypia

 

46%

11/24

Simpson et al. [6]

CGH

  

CCL with atypia

L

40%

4/10

Stacher et al. [26]

aCGH

  

CCL with atypia

L

70%

7/10

Go et al. [25]

FISH

 

16q12.3–13

CCL with atypia

Heteroz del

20%

2/10

Go et al. [25]

FISH

 

16q22.1

CCL with atypia

Heteroz del

10%

1/10

Go et al. [25]

FISH

 

16q23.2

CCL with atypia

Heteroz del

10%

1/10

  1. (a)CGH, (array) comparative genomic hybridization; CCL, columnar cell lesion;
  2. FISH, fluorescent in situ hybridization; LOH, loss of heterozygosity